PhosPrint
PhosPrint53About
What does PhosPrint do?
PhosPrint develops laser bioprinting systems for regenerative medicine and biosensor applications, enabling highly precise and rapid delivery of cells and bio-inks onto targeted tissues. Their lead program focuses on in-vivo printing for urinary bladder repair, having completed preclinical studies and advancing into clinical trials. The company's core product is the PhosDB I, a high-resolution laser bioprinter.
What is PhosPrint's revenue?
StartupHub estimates PhosPrint's annual revenue at $1.5M (range $865K to $2.4M, 64% confidence), based on comparable companies in the sector.
What is PhosPrint's valuation?
StartupHub estimates PhosPrint's effective valuation at $3.9M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.
How much funding has PhosPrint raised?
PhosPrint has raised a total of $1M in funding. The most recent round on record is Seed.
Where is PhosPrint headquartered?
PhosPrint is headquartered in Athens, Greece.
When was PhosPrint founded?
PhosPrint was founded in 2018.
What industry does PhosPrint operate in?
PhosPrint operates in Biotech, MedTech, HealthTech, 3D Printing, Advanced Manufacturing, Tissue Engineering.
How many employees does PhosPrint have?
PhosPrint has approximately 10 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.